Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PhaseBio Pharmaceuticals, Inc. PHAS

Set alert

Price alert · PHAS

All alert types
0.07 +0.07 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2022
50-d avg
0.00
200-d avg
0.00
1y target
1.00

1D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The one-day price history for PHAS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue → Gross Profit: $10.83KGross Profit → Expenses: $10.83KExpenses → Selling, General & Admin: $16.09KExpenses → Research & Development: $102.11KExpenses → Other Expenses: $22.11KExpenses → Income Tax: $1.60KNet Loss → Expenses: $131.07KGross Profit$10.83KNet Loss$131.07KExpenses$141.90KSelling, General & Admin$16.09KResearch & Development$102.11KOther Expenses$22.11KIncome Tax$1.60KRevenue$10.83K

No annual statement lines

PHAS has no annual lines for this statement.